Expect soaring effectiveness for weight-loss medications There will be more effective medications with a higher percentage of weight loss, such as Tirzepatide (single molecule, dual agonist)
As we can see from what happened in Canada, when generics come to market, patients will pay less
Similar content being viewed by others Introduction Glucagon-like peptide-1 (GLP-1) receptor agonists and sodiumglucose co-transporter 2 (SGLT2) inhibitors are modern antidiabetic agents that offer novel mechanisms of glycemic regulation, distinct from traditional therapies [1]
Supports skin rejuvenation, sleep, collagen production, and cellular longevity
Indirect Effect: By aggressively managing blood sugar and blood pressure, the medication reduces the "hyperfiltration" that damages the kidneys over time